Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report


  • Products Id :- 7B7C6D1D-5BBA-4854-A71D-B26D04B2ECD7
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Key Highlights

Progenics Pharmaceuticals (Progenics or 'the company') is a biopharmaceutical company focused on the development of medicines and products including therapeutic agents and imaging agents for targeting and treating cancer. The company operates in the US, where it is headquartered in New York.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Company Snapshot

Progenics Pharmaceuticals, Inc.: Company Overview

Progenics Pharmaceuticals, Inc.: Overview and Key Facts

Progenics Pharmaceuticals, Inc.: Overview

Progenics Pharmaceuticals, Inc.: Key Facts

Progenics Pharmaceuticals, Inc.: Key Employees

Progenics Pharmaceuticals, Inc.: Key Employee Biographies

Progenics Pharmaceuticals, Inc.: Major Products and Services

Progenics Pharmaceuticals, Inc.: Company History

Progenics Pharmaceuticals, Inc.: Management Statement

Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries

Progenics Pharmaceuticals, Inc.: Key Competitors

Progenics Pharmaceuticals, Inc.: Company Analysis

Progenics Pharmaceuticals, Inc.: Business Description

Progenics Pharmaceuticals, Inc.: SWOT Analysis

Progenics Pharmaceuticals, Inc.: SWOT Overview

Progenics Pharmaceuticals, Inc.: Strengths

Progenics Pharmaceuticals, Inc.: Weaknesses

Progenics Pharmaceuticals, Inc.: Opportunities

Progenics Pharmaceuticals, Inc.: Threats

Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Progenics Pharmaceuticals, Inc.: Financial Deals Overview

Progenics Pharmaceuticals, Inc.: Targets and Partners

Progenics Pharmaceuticals, Inc.: Top Deals 2013-2017YTD*

Progenics Pharmaceuticals, Inc.: Advisors

Progenics Pharmaceuticals, Inc.: Top Legal Advisors

Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions

Progenics Pharmaceuticals, Inc.: Capital Raising

Progenics Pharmaceuticals, Inc.: Partnership

Progenics Pharmaceuticals, Inc.: Recent Developments

Progenics Pharmaceuticals, Inc.: News and Events Summary

Progenics Pharmaceuticals, Inc.: Contracts

Progenics Pharmaceuticals, Inc.: Corporate Governance

Progenics Pharmaceuticals, Inc.: Financial Performance

Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events

Progenics Pharmaceuticals, Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Figure 3: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Figure 4: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Figure 5: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2013-YTD*2017)

Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2013-YTD*2017)

Figure 7: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2013-YTD*2017)

Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013-YTD*2017)

Figure 9: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013-YTD*2017)

Table 1: Progenics Pharmaceuticals, Inc.: Key Facts

Table 2: Progenics Pharmaceuticals, Inc.: Key Employees

Table 4: Progenics Pharmaceuticals, Inc.: Key Competitors

Table 5: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Table 7: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Table 8: Progenics Pharmaceuticals, Inc.: Targets and Partners

Table 9: Progenics Pharmaceuticals, Inc.: Top Deals 2013-2017YTD*

Table 10: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 11: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Table 12: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2013-YTD*2017)

Table 13: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2013-YTD*2017)

Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2013-YTD*2017)

Table 15: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013-YTD*2017)

Table 16: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013-YTD*2017)

Table 17: Progenics Pharmaceuticals, Inc.: News and Events Summary

Table 18: Progenics Pharmaceuticals, Inc.: Contracts

Table 19: Progenics Pharmaceuticals, Inc.: Corporate Governance

Table 20: Progenics Pharmaceuticals, Inc.: Financial Performance

Table 21: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 22: Progenics Pharmaceuticals, Inc.: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Progenics Pharmaceuticals, Inc.

select a license

Single User License
USD 175 INR 11261
Site License
USD 350 INR 22523
Corporate User License
USD 525 INR 33784

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com